Two projects of Arjen Blom and Peter van Lent, theme Inflammatory diseases, were granted by the Dutch Arthritis Association (ReumaNederland) (€ 160,000 per project).
Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint contributes to the pathophysiology and clinical symptoms.
Arjen Blom will focus on novel tools for imaging of early cartilage destruction for diagnostic purposes in rheumatic diseases.
Peter van Lent will focus on the therapeutic efficacy of fat derived stem cells in dampening synovitis and development of joint destruction in posttraumatic OA.
Related news items
Rob ter Horst in Dutch television broadcast Brandpunt Plus21 May 2019
In a Dutch television broadcast, called Brandpunt Plus, Rob ter Horst, PhD candidate, theme Infectious diseases and global health, explains how he records data about himself and what he hopes to find out about himself.read more
Dutch Kidney Foundation Innovation grant for Tom Nijenhuis14 May 2019
Tom Nijenhuis, theme Renal disorders, received this grant for his research project “Salt supplementation in Gitelman syndrome: A simple intervention using an innovative N-of-1 trial approach”.read more
Universal tumor BRCA1/2 testing of ovarian cancer13 May 2019
Marjolijn Ligtenberg, Janet Vos and Nicoline Hoogerbrugge, assessed the feasibility of a workflow for universal tumor DNA BRCA1/2 testing of all newly diagnosed OC patients as prescreen for PARPi treatment and cancer predisposition testing. They have published their findings in the JNCI.read more
A cozy relationship; the enhancer landscape of embryonic stem cells13 May 2019
In Nature Cell Biology, Yaser Atlasi, Wout Megchelenbrink and colleagues from the group of Henk Stunnenberg, theme Cancer development and immune defense, published a combination of experimental and bioinformatic approaches to study enhancer regulation in different states of embryonic stem cells.read more